Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system
Background Observational healthcare data offer the potential to enable identification of risks
of medical products, but appropriate methodology has not yet been defined. The self …
of medical products, but appropriate methodology has not yet been defined. The self …
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system
PB Ryan, MJ Schuemie, D Madigan - Drug safety, 2013 - pubmed.ncbi.nlm.nih.gov
Background Observational healthcare data offer the potential to enable identification of risks
of medical products, but appropriate methodology has not yet been defined. The self …
of medical products, but appropriate methodology has not yet been defined. The self …
Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System
PB Ryan, MJ Schuemie, D Madigan - Drug Safety, 2013 - search.proquest.com
This paper aims to evaluate the performance of the self-controlled cohort method as a tool
for risk identification in observational healthcare data. The method was applied to 399 drug …
for risk identification in observational healthcare data. The method was applied to 399 drug …
[引用][C] Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System
PB RYAN, MJ SCHUEMIE, D MADIGAN - Drug safety, 2013 - pascal-francis.inist.fr
Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk
Identification and Analysis System CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Identification and Analysis System CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System
PB Ryan, MJ Schuemie, D Madigan - Drug Safety, 2013 - infona.pl
Background Observational healthcare data offer the potential to enable identification of risks
of medical products, but appropriate methodology has not yet been defined. The self …
of medical products, but appropriate methodology has not yet been defined. The self …
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.
PB Ryan, MJ Schuemie, D Madigan - Drug Safety, 2013 - europepmc.org
Background Observational healthcare data offer the potential to enable identification of risks
of medical products, but appropriate methodology has not yet been defined. The self …
of medical products, but appropriate methodology has not yet been defined. The self …
Empirical performance of a self-controlled cohort method: Lessons for developing a risk identification and analysis system
P Ryan, M Schuemie, D Madigan - Drug Safety, 2013 - repub.eur.nl
Background Observational healthcare data offer the potential to enable identification of risks
of medical products, but appropriate methodology has not yet been defined. The self …
of medical products, but appropriate methodology has not yet been defined. The self …
Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System.
P Ryan, M Schuemie, D Madigan - Drug Safety, 2013 - search.ebscohost.com
Background: Observational healthcare data offer the potential to enable identification of risks
of medical products, but appropriate methodology has not yet been defined. The self …
of medical products, but appropriate methodology has not yet been defined. The self …